SEC Filings

Filing date	Form	Description	View
02/22/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-002435.pdf 0001179110-19-002435.rtf 0001179110-19-002435.xls
02/15/19	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-19-002018.pdf 0001179110-19-002018.rtf 0001179110-19-002018.xls
02/15/19	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-19-002019.pdf 0001179110-19-002019.rtf 0001179110-19-002019.xls
02/14/19	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001213900-19-002522.pdf 0001213900-19-002522.rtf 0001213900-19-002522.xls
02/14/19	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001213900-19-002526.pdf 0001213900-19-002526.rtf 0001213900-19-002526.xls
02/13/19	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-19-001362.pdf 0000315066-19-001362.rtf
02/12/19	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000932471-19-005763.pdf 0000932471-19-005763.rtf
02/07/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-001558.pdf 0001179110-19-001558.rtf 0001179110-19-001558.xls
02/07/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-001561.pdf 0001179110-19-001561.rtf 0001179110-19-001561.xls
02/07/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-001564.pdf 0001179110-19-001564.rtf 0001179110-19-001564.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools